Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Respiratory failure in patients undergoing allogeneic hematopoietic SCT—a randomized trial on early non-invasive ventilation based on standard care hematology wards

Bone Marrow Transplantation volume 47, pages 574–580 (2012)Cite this article

Abstract

The prognosis of patients suffering from respiratory failure (RF) after allogeneic hematopoietic SCT (HSCT) is poor. However, early treatment for using non-invasive ventilation (NIV) may be of benefit. We conducted a randomized trial to prove the impact of early NIV in patients in the early post-transplant period. A total of 526 patients undergoing HSCT in a single center were monitored for signs of RF. Patients with RF were enrolled into either treatment arm A (oxygen supply only) or treatment arm B (oxygen+intermittent NIV). RF had to be diagnosed in 86 patients (16%). RF was an independent risk factor for both short-term (100 day mortality/ OR 2.76; P<0.001) and long-term survival (OR 1.57; P<0.01). Although early RF treatment with NIV was associated with a decreased rate of failure to achieve sufficient oxygenation (39% in arm A vs 24% in arm B, P=0.17), neither intensive care unit admission rate, nor need for intubation or survival parameters were affected by the treatment strategy. An early interventional strategy using NIV was not associated with improvement of the prognosis of the patients. The limited influence of NIV may be related to the study design allowing for switching of treatment in case of unsatisfactory efficacy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Karanes C, Nelson GO, Chitphakdithai P, Agura E, Ballen KK, Bolan CD et al. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant 2008; 14: 8–15.

    Article  PubMed  Google Scholar 

  2. Bacigalupo A, Sormani MP, Lamparelli T, Gualandi F, Occhini D, Bregante S et al. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica 2004; 89: 1238–1247.

    PubMed  Google Scholar 

  3. Afessa B, Peters SG . Major complications following hematopoietic stem cell transplantation. Semin Respir Crit Care Med 2006; 27: 297–309.

    Article  PubMed  Google Scholar 

  4. Bach PB, Schrag D, Nierman DM, Horak D, White Jr P . Young JW et al. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001; 98: 3234–3240.

    Article  CAS  PubMed  Google Scholar 

  5. Savani BN, Montero A, Wu C, Nlonda N, Read E, Dunbar C et al. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 223–230.

    Article  PubMed  Google Scholar 

  6. Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ . Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 223–229.

    Article  CAS  PubMed  Google Scholar 

  7. Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 2006; 24: 643–649.

    Article  PubMed  Google Scholar 

  8. Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481–487.

    Article  CAS  PubMed  Google Scholar 

  9. Machin D, Campbell MJ, Fayers PM, Pinol APY . Sample Size Tables for Clinical Studies. Blackwell Science Ltd: Oxford, UK, 1997.

    Google Scholar 

  10. Ewig S, Torres A, Riquelme R, El-Ebiary M, Rovira M, Carreras E et al. Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU. Eur Respir J 1998; 12: 116–122.

    Article  CAS  PubMed  Google Scholar 

  11. Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H et al. Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 2000; 28: 1014–1017.

    Article  CAS  PubMed  Google Scholar 

  12. Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland HJ, Reece DE et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998; 21: 697–704.

    Article  CAS  PubMed  Google Scholar 

  13. Bernard GR . Acute respiratory distress syndrome: a historical perspective. Am J Respir Crit Care Med 2005; 172: 798–806.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Vital FM, Saconato H, Ladeira MT, Sen A, Hawkes CA, Soares B et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema. Cochrane Database Syst Rev 2008; issue 3, CD005351.

  15. Ram FS, Lightowler JV, Wedzicha JA . Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2003; issue 1, CD004104.

  16. Burns KE, Adhikari NK, Meade MO . Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respiratory failure. Cochrane Database Syst Rev 2003; CD004127.

Download references

Acknowledgements

The assistance of Catrin Theuser for statistical validation of the data is highly acknowledged.

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany

    M Wermke, S Schiemanck, G Höffken, G Ehninger, M Bornhäuser & T Illmer

Authors
  1. M Wermke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Schiemanck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Höffken
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Ehninger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Bornhäuser
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T Illmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T Illmer.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Bone Marrow Transplantation website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wermke, M., Schiemanck, S., Höffken, G. et al. Respiratory failure in patients undergoing allogeneic hematopoietic SCT—a randomized trial on early non-invasive ventilation based on standard care hematology wards. Bone Marrow Transplant 47, 574–580 (2012). https://doi.org/10.1038/bmt.2011.160

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.160

Keywords

This article is cited by

Search

Advanced search

Quick links